Trial Profile
Phase I trial of AGS 004 for prevention or delay of antiretroviral therapy (ART) initiation in ART-naive patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2010
Price :
$35
*
At a glance
- Drugs AGS 004 (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 09 Dec 2010 New trial record